{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:18:53Z","timestamp":1780723133927,"version":"3.54.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Penicillin allergy documentation in the electronic health record (EHR) lacks detail with regard to type of reaction, history of reaction, and other tolerated \u03b2-lactams. Because of concern for penicillin allergy cross-reactivity with cefazolin, patients with a reported penicillin allergy are frequently prescribed suboptimal preoperative antibiotics, which have been associated with negative patient outcomes, including increased risk of surgical site infection. The purpose of this study was to increase preoperative use of cefazolin via improvement to the documentation of penicillin allergies in the EHR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This single-center, quasi-experimental quality improvement study compared patients with a self-reported penicillin allergy admitted for select elective surgeries before and after implementation of a penicillin allergy questionnaire. The primary outcome was receipt of cefazolin for surgical prophylaxis. Secondary outcomes were the proportion of patients with detailed penicillin allergy documentation, the proportion of patients with surgical site infections occurring within 30 days of surgery, and the proportion of patients who received the full antibiotic dose before the first surgical incision.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 100 patients were included in the preintervention group, while 85 patients were included in the postintervention group. Cefazolin use was higher in the postintervention group (13.0% vs 41.2%; P &amp;lt; 0.001). The postintervention group also had a larger proportion of patients with detailed allergy documentation (2.0% vs 50.6%; P &amp;lt; 0.001) and who received the full preoperative antibiotic dose before the first incision (25.0% vs 48.2%; P = 0.001). There was no statistical difference between the groups in the incidence of surgical site infection at 30 days after surgery (3.0% vs 1.2%; P = 0.63).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Preoperative cefazolin use was higher in patients with a reported penicillin allergy after implementation of a penicillin allergy questionnaire and EHR documentation tool.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxae201","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:39:52Z","timestamp":1721439592000},"page":"S197-S205","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing preoperative antibiotic use through improved penicillin allergy documentation"],"prefix":"10.1093","volume":"81","author":[{"given":"Sarah A H","family":"Adams","sequence":"first","affiliation":[{"name":"Pharmacy Department, Piedmont Athens Regional Medical Center , Athens, GA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline D","family":"Gresham","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Piedmont Athens Regional Medical Center , Athens, GA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Ariail","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Piedmont Athens Regional Medical Center , Athens, GA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Curzio","family":"Rodeghiero","sequence":"additional","affiliation":[{"name":"Piedmont Direct Pharmacy , Piedmont Healthcare, Athens, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"issue":"6","key":"2024112206223648500_CIT0001","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2024112206223648500_CIT0002","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/pharmacy7020069","article-title":"Strategies for clarifying penicillin allergies when skin testing is not an option","volume":"7","author":"Covington","year":"2019","journal-title":"Pharmacy"},{"issue":"3","key":"2024112206223648500_CIT0003","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health-Syst Pharm"},{"issue":"5","key":"2024112206223648500_CIT0004","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ewjm.172.5.341","article-title":"Medical myth: ten percent of patients who are allergic to penicillin will have serious reactions if exposed to cephalosporins","volume":"172","author":"Herbert","year":"2000","journal-title":"West J Med"},{"issue":"4","key":"2024112206223648500_CIT0005","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1331\/JAPhA.2008.07006","article-title":"Cephalosporin use in treatment of patients with penicillin allergies","volume":"48","author":"DePestel","year":"2008","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"2024112206223648500_CIT0006","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2024112206223648500_CIT0007","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2024112206223648500_CIT0008","doi-asserted-by":"publisher","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of methicillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"2024112206223648500_CIT0009","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s11606-019-04991-y","article-title":"Recorded penicillin allergy and risk of mortality: a population-based matched cohort study","volume":"34","author":"Blumenthal","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2024112206223648500_CIT0010","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1093\/ajhp\/zxad023","article-title":"Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label","volume":"80","author":"Stonerock","year":"2023","journal-title":"Am J Health-Syst Pharm"},{"key":"2024112206223648500_CIT0011","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/ajhp\/zxab218","article-title":"Optimizing preoperative antibiotics in patients with \u03b2-lactam allergies: a role for pharmacy","volume":"78","author":"Kwaitkowski","year":"2021","journal-title":"Am J Health-Syst Pharm"},{"issue":"9","key":"2024112206223648500_CIT0012","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/jac\/dkx171","article-title":"Optimizing preoperative prophylaxis in patients with reported \u03b2-lactam allergy: a novel extension of antimicrobial stewardship","volume":"72","author":"Vaisman","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2024112206223648500_CIT0013","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/cid\/ciaa232","article-title":"Impact of an antibiotic side-chain-based cross-reactivity chart combined with enhanced allergy assessment processes for surgical prophylaxis antimicrobials in patients with \u03b2-lactam allergies","volume":"72","author":"Collins","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2024112206223648500_CIT0014","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"2024112206223648500_CIT0015","volume-title":"Drug Allergy (Quality Standard 97)","author":"National Institute for Health and Care Excellence","year":"2015"},{"issue":"5","key":"2024112206223648500_CIT0016","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2024112206223648500_CIT0017","volume-title":"Surgical Site Infection Event (SSI)","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"36","key":"2024112206223648500_CIT0018","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of Medicare care because of COVID-19 related concerns\u2013United States, June 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxae201\/58697961\/zxae201.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_5\/S197\/60775198\/zxae201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_5\/S197\/60775198\/zxae201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:30:48Z","timestamp":1732257048000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/81\/Supplement_5\/S197\/7717578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":18,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2024,7,20]]},"published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxae201","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,1]]},"published":{"date-parts":[[2024,7,20]]}}}